Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
74 |
1672 |
2.305e-18 |
6.566e-15 |
2 |
NEUROGENESIS |
67 |
1402 |
2.822e-18 |
6.566e-15 |
3 |
REGULATION OF CELL DIFFERENTIATION |
66 |
1492 |
2.604e-16 |
4.038e-13 |
4 |
ORGAN MORPHOGENESIS |
47 |
841 |
2.218e-15 |
2.58e-12 |
5 |
TISSUE DEVELOPMENT |
64 |
1518 |
8.026e-15 |
7.469e-12 |
6 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
54 |
1142 |
1.544e-14 |
1.166e-11 |
7 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
44 |
788 |
2.004e-14 |
1.166e-11 |
8 |
CIRCULATORY SYSTEM DEVELOPMENT |
44 |
788 |
2.004e-14 |
1.166e-11 |
9 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
60 |
1395 |
2.801e-14 |
1.448e-11 |
10 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
42 |
750 |
7.632e-14 |
3.551e-11 |
11 |
BLOOD VESSEL MORPHOGENESIS |
29 |
364 |
1.388e-13 |
5.869e-11 |
12 |
REGULATION OF CELL DEVELOPMENT |
44 |
836 |
1.58e-13 |
6.126e-11 |
13 |
VASCULATURE DEVELOPMENT |
32 |
469 |
5.037e-13 |
1.803e-10 |
14 |
NEURON DIFFERENTIATION |
44 |
874 |
7.254e-13 |
2.411e-10 |
15 |
TUBE DEVELOPMENT |
34 |
552 |
1.623e-12 |
5.034e-10 |
16 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
47 |
1021 |
2.633e-12 |
7.656e-10 |
17 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
65 |
1784 |
3.868e-12 |
1.059e-09 |
18 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
53 |
1275 |
4.433e-12 |
1.146e-09 |
19 |
REGULATION OF CELL PROLIFERATION |
58 |
1496 |
6.185e-12 |
1.515e-09 |
20 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
61 |
1656 |
1.336e-11 |
3.108e-09 |
21 |
CELL FATE COMMITMENT |
21 |
227 |
2.237e-11 |
4.956e-09 |
22 |
POSITIVE REGULATION OF GENE EXPRESSION |
62 |
1733 |
2.963e-11 |
6.267e-09 |
23 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
44 |
983 |
3.609e-11 |
7.301e-09 |
24 |
LOCOMOTION |
47 |
1114 |
5.332e-11 |
1.034e-08 |
25 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
38 |
771 |
5.88e-11 |
1.094e-08 |
26 |
UROGENITAL SYSTEM DEVELOPMENT |
23 |
299 |
1.042e-10 |
1.866e-08 |
27 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
38 |
801 |
1.765e-10 |
3.041e-08 |
28 |
REGULATION OF NEURON DIFFERENTIATION |
31 |
554 |
1.851e-10 |
3.076e-08 |
29 |
REGULATION OF MAPK CASCADE |
34 |
660 |
2.074e-10 |
3.327e-08 |
30 |
REGULATION OF CELL PROJECTION ORGANIZATION |
31 |
558 |
2.21e-10 |
3.428e-08 |
31 |
EMBRYO DEVELOPMENT |
40 |
894 |
3.165e-10 |
4.751e-08 |
32 |
POSITIVE REGULATION OF CELL COMMUNICATION |
55 |
1532 |
4.361e-10 |
5.369e-08 |
33 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
61 |
1805 |
4.401e-10 |
5.369e-08 |
34 |
REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL |
11 |
55 |
3.735e-10 |
5.369e-08 |
35 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
62 |
1848 |
4.084e-10 |
5.369e-08 |
36 |
EMBRYONIC MORPHOGENESIS |
30 |
539 |
4.212e-10 |
5.369e-08 |
37 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
59 |
1710 |
4.118e-10 |
5.369e-08 |
38 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
32 |
609 |
4.5e-10 |
5.369e-08 |
39 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
57 |
1618 |
4.005e-10 |
5.369e-08 |
40 |
EPITHELIUM DEVELOPMENT |
41 |
945 |
4.652e-10 |
5.412e-08 |
41 |
RESPONSE TO ENDOGENOUS STIMULUS |
53 |
1450 |
5.107e-10 |
5.796e-08 |
42 |
REGULATION OF CELL DEATH |
53 |
1472 |
8.716e-10 |
9.656e-08 |
43 |
POSITIVE REGULATION OF CELL PROLIFERATION |
37 |
814 |
1.021e-09 |
1.105e-07 |
44 |
SENSORY ORGAN DEVELOPMENT |
28 |
493 |
1.063e-09 |
1.125e-07 |
45 |
HEAD DEVELOPMENT |
34 |
709 |
1.332e-09 |
1.377e-07 |
46 |
TISSUE MORPHOGENESIS |
29 |
533 |
1.412e-09 |
1.379e-07 |
47 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
50 |
1360 |
1.422e-09 |
1.379e-07 |
48 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
37 |
823 |
1.378e-09 |
1.379e-07 |
49 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
38 |
872 |
1.915e-09 |
1.818e-07 |
50 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
42 |
1036 |
2.129e-09 |
1.942e-07 |
51 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
42 |
1036 |
2.129e-09 |
1.942e-07 |
52 |
ANGIOGENESIS |
21 |
293 |
2.492e-09 |
2.23e-07 |
53 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
44 |
1135 |
3.292e-09 |
2.89e-07 |
54 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
16 |
167 |
3.424e-09 |
2.951e-07 |
55 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
45 |
1192 |
4.809e-09 |
4.069e-07 |
56 |
NEGATIVE REGULATION OF CELL DEATH |
37 |
872 |
6.505e-09 |
5.405e-07 |
57 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
25 |
437 |
7.527e-09 |
6.144e-07 |
58 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
20 |
285 |
8.647e-09 |
6.937e-07 |
59 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
24 |
408 |
8.895e-09 |
7.015e-07 |
60 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
14 |
133 |
9.893e-09 |
7.546e-07 |
61 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
40 |
1008 |
9.795e-09 |
7.546e-07 |
62 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
51 |
1492 |
1.092e-08 |
8.199e-07 |
63 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
60 |
1929 |
1.451e-08 |
1.072e-06 |
64 |
CELL DEVELOPMENT |
49 |
1426 |
1.893e-08 |
1.355e-06 |
65 |
BIOLOGICAL ADHESION |
40 |
1032 |
1.875e-08 |
1.355e-06 |
66 |
CELL MOTILITY |
35 |
835 |
2.351e-08 |
1.633e-06 |
67 |
LOCALIZATION OF CELL |
35 |
835 |
2.351e-08 |
1.633e-06 |
68 |
TAXIS |
25 |
464 |
2.464e-08 |
1.686e-06 |
69 |
MORPHOGENESIS OF AN EPITHELIUM |
23 |
400 |
2.795e-08 |
1.885e-06 |
70 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
25 |
472 |
3.441e-08 |
2.287e-06 |
71 |
RESPONSE TO GROWTH FACTOR |
25 |
475 |
3.892e-08 |
2.551e-06 |
72 |
EPITHELIAL CELL FATE COMMITMENT |
6 |
15 |
4.208e-08 |
2.719e-06 |
73 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
32 |
740 |
4.833e-08 |
3.081e-06 |
74 |
BEHAVIOR |
26 |
516 |
4.922e-08 |
3.095e-06 |
75 |
REGULATION OF TRANSPORT |
56 |
1804 |
5.271e-08 |
3.27e-06 |
76 |
SINGLE ORGANISM BEHAVIOR |
22 |
384 |
6.029e-08 |
3.691e-06 |
77 |
NEURON PROJECTION GUIDANCE |
16 |
205 |
6.367e-08 |
3.848e-06 |
78 |
REGULATION OF VASCULATURE DEVELOPMENT |
17 |
233 |
6.592e-08 |
3.933e-06 |
79 |
TUBE MORPHOGENESIS |
20 |
323 |
6.962e-08 |
4.101e-06 |
80 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
37 |
957 |
7.229e-08 |
4.205e-06 |
81 |
MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL |
8 |
39 |
8e-08 |
4.596e-06 |
82 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
38 |
1004 |
8.185e-08 |
4.644e-06 |
83 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
33 |
799 |
8.641e-08 |
4.844e-06 |
84 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
55 |
1791 |
1.018e-07 |
5.642e-06 |
85 |
HEART DEVELOPMENT |
24 |
466 |
1.101e-07 |
6.027e-06 |
86 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
30 |
689 |
1.126e-07 |
6.091e-06 |
87 |
ACTION POTENTIAL |
11 |
94 |
1.3e-07 |
6.95e-06 |
88 |
NEURON PROJECTION DEVELOPMENT |
26 |
545 |
1.443e-07 |
7.632e-06 |
89 |
CELLULAR COMPONENT MORPHOGENESIS |
35 |
900 |
1.466e-07 |
7.666e-06 |
90 |
EMBRYONIC ORGAN DEVELOPMENT |
22 |
406 |
1.591e-07 |
8.225e-06 |
91 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
25 |
513 |
1.699e-07 |
8.686e-06 |
92 |
REGULATION OF MEMBRANE POTENTIAL |
20 |
343 |
1.845e-07 |
9.33e-06 |
93 |
NEGATIVE REGULATION OF GENE EXPRESSION |
48 |
1493 |
2.03e-07 |
1.005e-05 |
94 |
REGULATION OF ION TRANSPORT |
27 |
592 |
2.022e-07 |
1.005e-05 |
95 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
35 |
917 |
2.29e-07 |
1.122e-05 |
96 |
POSITIVE REGULATION OF LOCOMOTION |
22 |
420 |
2.846e-07 |
1.365e-05 |
97 |
SKELETAL SYSTEM DEVELOPMENT |
23 |
455 |
2.844e-07 |
1.365e-05 |
98 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
16 |
229 |
2.914e-07 |
1.375e-05 |
99 |
REGULATION OF DEVELOPMENTAL GROWTH |
18 |
289 |
2.926e-07 |
1.375e-05 |
100 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
22 |
422 |
3.085e-07 |
1.436e-05 |
101 |
CELL CELL SIGNALING |
31 |
767 |
3.503e-07 |
1.598e-05 |
102 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
16 |
232 |
3.475e-07 |
1.598e-05 |
103 |
EYE DEVELOPMENT |
19 |
326 |
3.789e-07 |
1.712e-05 |
104 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
23 |
465 |
4.162e-07 |
1.862e-05 |
105 |
FAT CELL DIFFERENTIATION |
11 |
106 |
4.479e-07 |
1.985e-05 |
106 |
AMEBOIDAL TYPE CELL MIGRATION |
13 |
154 |
4.543e-07 |
1.994e-05 |
107 |
CELL PROJECTION ORGANIZATION |
34 |
902 |
4.608e-07 |
2.004e-05 |
108 |
POSITIVE REGULATION OF MAPK CASCADE |
23 |
470 |
5.014e-07 |
2.16e-05 |
109 |
REGULATION OF SYSTEM PROCESS |
24 |
507 |
5.109e-07 |
2.181e-05 |
110 |
SYSTEM PROCESS |
53 |
1785 |
5.248e-07 |
2.22e-05 |
111 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
18 |
303 |
5.852e-07 |
2.453e-05 |
112 |
REGULATION OF ORGAN MORPHOGENESIS |
16 |
242 |
6.124e-07 |
2.544e-05 |
113 |
NEURON MIGRATION |
11 |
110 |
6.523e-07 |
2.686e-05 |
114 |
CELL PROLIFERATION |
28 |
672 |
7.361e-07 |
3.005e-05 |
115 |
GROWTH |
21 |
410 |
7.684e-07 |
3.109e-05 |
116 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
34 |
926 |
8.362e-07 |
3.354e-05 |
117 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
44 |
1381 |
9.007e-07 |
3.582e-05 |
118 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
11 |
114 |
9.348e-07 |
3.686e-05 |
119 |
RESPONSE TO WOUNDING |
25 |
563 |
9.505e-07 |
3.717e-05 |
120 |
RESPONSE TO EXTERNAL STIMULUS |
53 |
1821 |
9.68e-07 |
3.754e-05 |
121 |
COGNITION |
16 |
251 |
9.944e-07 |
3.793e-05 |
122 |
REGULATION OF LIPID METABOLIC PROCESS |
17 |
282 |
9.884e-07 |
3.793e-05 |
123 |
REGULATION OF EPITHELIAL CELL MIGRATION |
13 |
166 |
1.071e-06 |
4.052e-05 |
124 |
CELL ACTIVATION |
25 |
568 |
1.116e-06 |
4.186e-05 |
125 |
NEURON DEVELOPMENT |
28 |
687 |
1.136e-06 |
4.229e-05 |
126 |
EPITHELIAL CELL DIFFERENTIATION |
23 |
495 |
1.223e-06 |
4.516e-05 |
127 |
RESPIRATORY SYSTEM DEVELOPMENT |
14 |
197 |
1.327e-06 |
4.862e-05 |
128 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
12 |
144 |
1.448e-06 |
5.265e-05 |
129 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
24 |
541 |
1.607e-06 |
5.753e-05 |
130 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
24 |
541 |
1.607e-06 |
5.753e-05 |
131 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
46 |
1517 |
1.916e-06 |
6.807e-05 |
132 |
REGULATION OF HYDROLASE ACTIVITY |
42 |
1327 |
1.953e-06 |
6.834e-05 |
133 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
46 |
1518 |
1.951e-06 |
6.834e-05 |
134 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
32 |
876 |
2.009e-06 |
6.977e-05 |
135 |
REGULATION OF SYNAPSE ASSEMBLY |
9 |
79 |
2.307e-06 |
7.95e-05 |
136 |
KIDNEY EPITHELIUM DEVELOPMENT |
11 |
125 |
2.336e-06 |
7.994e-05 |
137 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
14 |
207 |
2.385e-06 |
8.099e-05 |
138 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
38 |
1152 |
2.432e-06 |
8.199e-05 |
139 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
18 |
337 |
2.678e-06 |
8.899e-05 |
140 |
RESPONSE TO LIPID |
32 |
888 |
2.674e-06 |
8.899e-05 |
141 |
NEURONAL ACTION POTENTIAL |
6 |
28 |
2.698e-06 |
8.903e-05 |
142 |
POSITIVE REGULATION OF KINASE ACTIVITY |
22 |
482 |
2.802e-06 |
9.182e-05 |
143 |
MEMBRANE DEPOLARIZATION |
8 |
61 |
2.897e-06 |
9.425e-05 |
144 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
12 |
154 |
2.938e-06 |
9.493e-05 |
145 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
17 |
306 |
3.008e-06 |
9.653e-05 |
146 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
16 |
274 |
3.119e-06 |
9.941e-05 |
147 |
HEART MORPHOGENESIS |
14 |
212 |
3.154e-06 |
9.984e-05 |
148 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
26 |
643 |
3.223e-06 |
0.0001013 |
149 |
REGULATION OF RESPONSE TO WOUNDING |
20 |
413 |
3.325e-06 |
0.0001038 |
150 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
11 |
131 |
3.699e-06 |
0.0001147 |
151 |
SPROUTING ANGIOGENESIS |
7 |
45 |
3.798e-06 |
0.000117 |
152 |
EMBRYONIC ORGAN MORPHOGENESIS |
16 |
279 |
3.934e-06 |
0.0001204 |
153 |
REGULATION OF KINASE ACTIVITY |
29 |
776 |
4.032e-06 |
0.0001226 |
154 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
36 |
1087 |
4.2e-06 |
0.0001269 |
155 |
CELLULAR RESPONSE TO LIPID |
21 |
457 |
4.272e-06 |
0.0001283 |
156 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
25 |
616 |
4.707e-06 |
0.0001393 |
157 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
22 |
498 |
4.732e-06 |
0.0001393 |
158 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
25 |
616 |
4.707e-06 |
0.0001393 |
159 |
CHEMICAL HOMEOSTASIS |
31 |
874 |
5.332e-06 |
0.000156 |
160 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
11 |
138 |
6.127e-06 |
0.0001779 |
161 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
16 |
289 |
6.156e-06 |
0.0001779 |
162 |
REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY |
5 |
19 |
6.408e-06 |
0.0001822 |
163 |
EAR DEVELOPMENT |
13 |
195 |
6.407e-06 |
0.0001822 |
164 |
REGULATION OF STEM CELL DIFFERENTIATION |
10 |
113 |
6.421e-06 |
0.0001822 |
165 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
21 |
470 |
6.576e-06 |
0.0001854 |
166 |
RESPONSE TO ALCOHOL |
18 |
362 |
7.223e-06 |
0.0002025 |
167 |
TELENCEPHALON DEVELOPMENT |
14 |
228 |
7.315e-06 |
0.0002038 |
168 |
REGULATION OF GROWTH |
25 |
633 |
7.535e-06 |
0.0002075 |
169 |
NEPHRON DEVELOPMENT |
10 |
115 |
7.513e-06 |
0.0002075 |
170 |
REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
7 |
50 |
7.853e-06 |
0.0002149 |
171 |
NEURON PROJECTION MORPHOGENESIS |
19 |
402 |
8.293e-06 |
0.0002256 |
172 |
RESPONSE TO FLUID SHEAR STRESS |
6 |
34 |
8.945e-06 |
0.000242 |
173 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
18 |
368 |
9.039e-06 |
0.0002431 |
174 |
DEVELOPMENTAL GROWTH |
17 |
333 |
9.227e-06 |
0.0002467 |
175 |
REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
10 |
118 |
9.451e-06 |
0.0002513 |
176 |
SYNAPSE ORGANIZATION |
11 |
145 |
9.844e-06 |
0.0002602 |
177 |
MODULATION OF SYNAPTIC TRANSMISSION |
16 |
301 |
1.026e-05 |
0.0002698 |
178 |
REGULATION OF HOMEOSTATIC PROCESS |
20 |
447 |
1.073e-05 |
0.0002789 |
179 |
POSITIVE REGULATION OF CELL DEATH |
24 |
605 |
1.072e-05 |
0.0002789 |
180 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
10 |
121 |
1.181e-05 |
0.0003052 |
181 |
LEUKOCYTE ACTIVATION |
19 |
414 |
1.255e-05 |
0.0003225 |
182 |
MULTICELLULAR ORGANISMAL SIGNALING |
10 |
123 |
1.364e-05 |
0.0003488 |
183 |
SENSORY PERCEPTION OF PAIN |
8 |
75 |
1.39e-05 |
0.0003534 |
184 |
REGULATION OF CHEMOTAXIS |
12 |
180 |
1.455e-05 |
0.0003679 |
185 |
MUSCLE ORGAN DEVELOPMENT |
15 |
277 |
1.562e-05 |
0.0003928 |
186 |
POSITIVE REGULATION OF BINDING |
10 |
127 |
1.807e-05 |
0.000452 |
187 |
WNT SIGNALING PATHWAY |
17 |
351 |
1.822e-05 |
0.0004535 |
188 |
REGULATION OF TRANSMEMBRANE TRANSPORT |
19 |
426 |
1.866e-05 |
0.000462 |
189 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
21 |
505 |
1.937e-05 |
0.0004742 |
190 |
POSITIVE REGULATION OF LIPID METABOLIC PROCESS |
10 |
128 |
1.935e-05 |
0.0004742 |
191 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
11 |
156 |
1.963e-05 |
0.0004783 |
192 |
REGULATION OF CELL ADHESION |
24 |
629 |
2.024e-05 |
0.0004906 |
193 |
REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY |
4 |
12 |
2.036e-05 |
0.0004909 |
194 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
9 |
103 |
2.07e-05 |
0.0004966 |
195 |
REGULATION OF MAP KINASE ACTIVITY |
16 |
319 |
2.102e-05 |
0.0005015 |
196 |
REGULATION OF GTPASE ACTIVITY |
25 |
673 |
2.121e-05 |
0.0005034 |
197 |
RESPONSE TO HORMONE |
30 |
893 |
2.152e-05 |
0.0005084 |
198 |
BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
5 |
24 |
2.206e-05 |
0.0005184 |
199 |
FOREBRAIN DEVELOPMENT |
17 |
357 |
2.262e-05 |
0.000529 |
200 |
REGULATION OF RESPONSE TO STRESS |
42 |
1468 |
2.307e-05 |
0.0005366 |
201 |
REGULATION OF CELL MORPHOGENESIS |
22 |
552 |
2.347e-05 |
0.0005433 |
202 |
NEGATIVE REGULATION OF HYDROLASE ACTIVITY |
18 |
397 |
2.497e-05 |
0.0005752 |
203 |
REGULATION OF TRANSFERASE ACTIVITY |
31 |
946 |
2.513e-05 |
0.000576 |
204 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
27 |
767 |
2.538e-05 |
0.0005789 |
205 |
REGULATION OF FAT CELL DIFFERENTIATION |
9 |
106 |
2.607e-05 |
0.0005918 |
206 |
STEM CELL PROLIFERATION |
7 |
60 |
2.68e-05 |
0.0006053 |
207 |
ANION HOMEOSTASIS |
6 |
41 |
2.744e-05 |
0.0006168 |
208 |
RESPONSE TO RETINOIC ACID |
9 |
107 |
2.811e-05 |
0.0006288 |
209 |
POSITIVE REGULATION OF SYNAPSE ASSEMBLY |
7 |
61 |
2.99e-05 |
0.0006656 |
210 |
REGULATION OF CELL ACTIVATION |
20 |
484 |
3.347e-05 |
0.0007321 |
211 |
FOREBRAIN CELL MIGRATION |
7 |
62 |
3.328e-05 |
0.0007321 |
212 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
18 |
406 |
3.352e-05 |
0.0007321 |
213 |
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
7 |
62 |
3.328e-05 |
0.0007321 |
214 |
PALATE DEVELOPMENT |
8 |
85 |
3.495e-05 |
0.0007564 |
215 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
11 |
166 |
3.495e-05 |
0.0007564 |
216 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
12 |
197 |
3.563e-05 |
0.0007639 |
217 |
SECRETION BY CELL |
20 |
486 |
3.546e-05 |
0.0007639 |
218 |
NEGATIVE REGULATION OF LOCOMOTION |
14 |
263 |
3.616e-05 |
0.0007713 |
219 |
CEREBRAL CORTEX CELL MIGRATION |
6 |
43 |
3.63e-05 |
0.0007713 |
220 |
RHYTHMIC PROCESS |
15 |
298 |
3.652e-05 |
0.0007723 |
221 |
POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
4 |
14 |
4.023e-05 |
0.000845 |
222 |
AXIS ELONGATION |
5 |
27 |
4.042e-05 |
0.000845 |
223 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
13 |
232 |
4.05e-05 |
0.000845 |
224 |
APPENDAGE DEVELOPMENT |
11 |
169 |
4.12e-05 |
0.000852 |
225 |
LIMB DEVELOPMENT |
11 |
169 |
4.12e-05 |
0.000852 |
226 |
REGULATION OF SYNAPSE ORGANIZATION |
9 |
113 |
4.336e-05 |
0.0008927 |
227 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
15 |
303 |
4.417e-05 |
0.0009054 |
228 |
POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
8 |
88 |
4.494e-05 |
0.0009171 |
229 |
REGULATION OF BEHAVIOR |
7 |
65 |
4.539e-05 |
0.0009182 |
230 |
CELLULAR RESPONSE TO RETINOIC ACID |
7 |
65 |
4.539e-05 |
0.0009182 |
231 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
15 |
304 |
4.586e-05 |
0.0009238 |
232 |
CATION TRANSPORT |
27 |
796 |
4.802e-05 |
0.0009632 |
233 |
REGULATION OF FATTY ACID OXIDATION |
5 |
28 |
4.861e-05 |
0.0009654 |
234 |
REGULATION OF SPROUTING ANGIOGENESIS |
5 |
28 |
4.861e-05 |
0.0009654 |
235 |
POST EMBRYONIC DEVELOPMENT |
8 |
89 |
4.876e-05 |
0.0009654 |
236 |
IMMUNE SYSTEM DEVELOPMENT |
22 |
582 |
5.181e-05 |
0.001022 |
237 |
SODIUM ION TRANSMEMBRANE TRANSPORT |
8 |
90 |
5.285e-05 |
0.001029 |
238 |
ENDOTHELIUM DEVELOPMENT |
8 |
90 |
5.285e-05 |
0.001029 |
239 |
POSITIVE REGULATION OF GROWTH |
13 |
238 |
5.267e-05 |
0.001029 |
240 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
10 |
144 |
5.331e-05 |
0.001034 |
241 |
CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS |
4 |
15 |
5.423e-05 |
0.001047 |
242 |
SENSORY ORGAN MORPHOGENESIS |
13 |
239 |
5.498e-05 |
0.001057 |
243 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
7 |
67 |
5.53e-05 |
0.001059 |
244 |
REGULATION OF WNT SIGNALING PATHWAY |
15 |
310 |
5.725e-05 |
0.001092 |
245 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
12 |
207 |
5.766e-05 |
0.001095 |
246 |
SECRETION |
22 |
588 |
6.025e-05 |
0.00114 |
247 |
CELL PART MORPHOGENESIS |
23 |
633 |
6.387e-05 |
0.001203 |
248 |
REGULATION OF OSSIFICATION |
11 |
178 |
6.604e-05 |
0.001239 |
249 |
HOMEOSTATIC PROCESS |
38 |
1337 |
6.771e-05 |
0.001265 |
250 |
RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE |
4 |
16 |
7.148e-05 |
0.00133 |
251 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
21 |
554 |
7.384e-05 |
0.001369 |
252 |
MUSCLE STRUCTURE DEVELOPMENT |
18 |
432 |
7.457e-05 |
0.001377 |
253 |
RESPONSE TO ACID CHEMICAL |
15 |
319 |
7.897e-05 |
0.001452 |
254 |
MONOVALENT INORGANIC CATION TRANSPORT |
18 |
435 |
8.141e-05 |
0.001491 |
255 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
18 |
437 |
8.627e-05 |
0.001574 |
256 |
ENDOTHELIAL CELL DIFFERENTIATION |
7 |
72 |
8.801e-05 |
0.0016 |
257 |
PALLIUM DEVELOPMENT |
10 |
153 |
8.88e-05 |
0.001605 |
258 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
24 |
691 |
8.902e-05 |
0.001605 |
259 |
BRANCH ELONGATION OF AN EPITHELIUM |
4 |
17 |
9.239e-05 |
0.001654 |
260 |
REGULATION OF ENERGY HOMEOSTASIS |
4 |
17 |
9.239e-05 |
0.001654 |
261 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
7 |
73 |
9.614e-05 |
0.001714 |
262 |
MEMORY |
8 |
98 |
9.699e-05 |
0.00172 |
263 |
ARTERY MORPHOGENESIS |
6 |
51 |
9.722e-05 |
0.00172 |
264 |
CELL CELL ADHESION |
22 |
608 |
9.798e-05 |
0.001727 |
265 |
BONE DEVELOPMENT |
10 |
156 |
0.0001044 |
0.001833 |
266 |
REGULATION OF SECRETION |
24 |
699 |
0.0001061 |
0.001856 |
267 |
CIRCULATORY SYSTEM PROCESS |
16 |
366 |
0.0001077 |
0.001878 |
268 |
INTRACELLULAR SIGNAL TRANSDUCTION |
42 |
1572 |
0.0001093 |
0.001897 |
269 |
LEUKOCYTE DIFFERENTIATION |
14 |
292 |
0.0001111 |
0.001922 |
270 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
4 |
18 |
0.0001174 |
0.002024 |
271 |
MESENCHYME DEVELOPMENT |
11 |
190 |
0.0001184 |
0.002032 |
272 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
6 |
53 |
0.0001209 |
0.002069 |
273 |
REGULATION OF BLOOD CIRCULATION |
14 |
295 |
0.0001237 |
0.002108 |
274 |
ION HOMEOSTASIS |
21 |
576 |
0.0001272 |
0.002159 |
275 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
8 |
102 |
0.0001285 |
0.002175 |
276 |
TRANSMISSION OF NERVE IMPULSE |
6 |
54 |
0.0001344 |
0.002266 |
277 |
REGULATION OF BMP SIGNALING PATHWAY |
7 |
77 |
0.000135 |
0.002268 |
278 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
13 |
262 |
0.0001387 |
0.002322 |
279 |
CONNECTIVE TISSUE DEVELOPMENT |
11 |
194 |
0.0001423 |
0.002373 |
280 |
MAINTENANCE OF CELL NUMBER |
9 |
132 |
0.0001447 |
0.002405 |
281 |
RESPONSE TO STEROID HORMONE |
19 |
497 |
0.0001459 |
0.002415 |
282 |
RENAL TUBULE DEVELOPMENT |
7 |
78 |
0.0001465 |
0.002417 |
283 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
8 |
104 |
0.0001472 |
0.002419 |
284 |
RESPONSE TO MONOAMINE |
5 |
35 |
0.0001477 |
0.002419 |
285 |
CEREBRAL CORTEX DEVELOPMENT |
8 |
105 |
0.0001573 |
0.00256 |
286 |
ODONTOGENESIS |
8 |
105 |
0.0001573 |
0.00256 |
287 |
REGULATION OF DENDRITIC SPINE DEVELOPMENT |
6 |
56 |
0.0001649 |
0.002673 |
288 |
REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
5 |
36 |
0.0001694 |
0.002728 |
289 |
POSITIVE CHEMOTAXIS |
5 |
36 |
0.0001694 |
0.002728 |
290 |
LYMPHOCYTE ACTIVATION |
15 |
342 |
0.0001701 |
0.002729 |
291 |
REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE |
6 |
57 |
0.000182 |
0.002881 |
292 |
ENDOTHELIAL CELL MIGRATION |
6 |
57 |
0.000182 |
0.002881 |
293 |
REGULATION OF NEURON PROJECTION REGENERATION |
4 |
20 |
0.0001817 |
0.002881 |
294 |
EYE MORPHOGENESIS |
9 |
136 |
0.0001814 |
0.002881 |
295 |
HINDBRAIN DEVELOPMENT |
9 |
137 |
0.0001918 |
0.003025 |
296 |
SKELETAL SYSTEM MORPHOGENESIS |
11 |
201 |
0.000194 |
0.003049 |
297 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
12 |
236 |
0.0001991 |
0.003119 |
298 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
23 |
684 |
0.0002001 |
0.003124 |
299 |
WOUND HEALING |
18 |
470 |
0.0002129 |
0.003313 |
300 |
POSITIVE REGULATION OF CELL ACTIVATION |
14 |
311 |
0.0002139 |
0.003318 |
301 |
REGULATION OF ERK1 AND ERK2 CASCADE |
12 |
238 |
0.0002152 |
0.003327 |
302 |
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY |
8 |
110 |
0.0002171 |
0.003345 |
303 |
POSITIVE REGULATION OF ORGAN GROWTH |
5 |
38 |
0.0002203 |
0.003383 |
304 |
NEGATIVE REGULATION OF NEURON DEATH |
10 |
171 |
0.0002215 |
0.003391 |
305 |
REGULATION OF SYNAPTIC PLASTICITY |
9 |
140 |
0.0002256 |
0.003434 |
306 |
RESPONSE TO DRUG |
17 |
431 |
0.0002258 |
0.003434 |
307 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
8 |
111 |
0.0002311 |
0.003502 |
308 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
7 |
84 |
0.0002331 |
0.00351 |
309 |
TISSUE MIGRATION |
7 |
84 |
0.0002331 |
0.00351 |
310 |
REGULATION OF CELLULAR KETONE METABOLIC PROCESS |
10 |
173 |
0.0002433 |
0.003652 |
311 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
8 |
112 |
0.0002457 |
0.003676 |
312 |
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
13 |
278 |
0.000248 |
0.003699 |
313 |
NEGATIVE CHEMOTAXIS |
5 |
39 |
0.0002497 |
0.003712 |
314 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
13 |
279 |
0.0002568 |
0.003805 |
315 |
OVULATION CYCLE |
8 |
113 |
0.0002611 |
0.003857 |
316 |
CELLULAR RESPONSE TO ACID CHEMICAL |
10 |
175 |
0.0002669 |
0.003922 |
317 |
CEREBELLAR CORTEX FORMATION |
4 |
22 |
0.000268 |
0.003922 |
318 |
AORTA MORPHOGENESIS |
4 |
22 |
0.000268 |
0.003922 |
319 |
LYMPHOCYTE DIFFERENTIATION |
11 |
209 |
0.0002718 |
0.003965 |
320 |
REGULATION OF EMBRYONIC DEVELOPMENT |
8 |
114 |
0.0002773 |
0.004033 |
321 |
SODIUM ION TRANSPORT |
9 |
144 |
0.0002784 |
0.004036 |
322 |
FORELIMB MORPHOGENESIS |
5 |
40 |
0.000282 |
0.004074 |
323 |
REGULATION OF FATTY ACID METABOLIC PROCESS |
7 |
87 |
0.0002897 |
0.004173 |
324 |
NEGATIVE REGULATION OF MAPK CASCADE |
9 |
145 |
0.0002931 |
0.00421 |
325 |
OVULATION CYCLE PROCESS |
7 |
88 |
0.0003109 |
0.004437 |
326 |
NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
7 |
88 |
0.0003109 |
0.004437 |
327 |
FEMALE SEX DIFFERENTIATION |
8 |
116 |
0.0003122 |
0.004442 |
328 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
5 |
41 |
0.0003173 |
0.00446 |
329 |
AORTA DEVELOPMENT |
5 |
41 |
0.0003173 |
0.00446 |
330 |
NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE |
5 |
41 |
0.0003173 |
0.00446 |
331 |
NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
5 |
41 |
0.0003173 |
0.00446 |
332 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
16 |
404 |
0.0003289 |
0.004609 |
333 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
8 |
117 |
0.0003309 |
0.004624 |
334 |
EPITHELIAL CELL PROLIFERATION |
7 |
89 |
0.0003332 |
0.004642 |
335 |
NEUROLOGICAL SYSTEM PROCESS |
34 |
1242 |
0.000336 |
0.004667 |
336 |
DIGESTIVE SYSTEM DEVELOPMENT |
9 |
148 |
0.0003411 |
0.004723 |
337 |
REGULATION OF PHOSPHOLIPASE ACTIVITY |
6 |
64 |
0.0003452 |
0.004752 |
338 |
REGULATION OF NEUROTRANSMITTER TRANSPORT |
6 |
64 |
0.0003452 |
0.004752 |
339 |
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY |
5 |
42 |
0.0003559 |
0.004885 |
340 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
11 |
216 |
0.0003601 |
0.004928 |
341 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
16 |
408 |
0.0003665 |
0.004987 |
342 |
REGULATION OF PROTEIN LOCALIZATION |
28 |
950 |
0.0003655 |
0.004987 |
343 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
27 |
905 |
0.0003863 |
0.00524 |
344 |
METAL ION TRANSPORT |
20 |
582 |
0.0003952 |
0.005346 |
345 |
CELL FATE DETERMINATION |
5 |
43 |
0.000398 |
0.005353 |
346 |
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION |
10 |
184 |
0.000398 |
0.005353 |
347 |
NEPHRON EPITHELIUM DEVELOPMENT |
7 |
93 |
0.000436 |
0.005829 |
348 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
9 |
153 |
0.0004353 |
0.005829 |
349 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
8 |
122 |
0.0004388 |
0.005851 |
350 |
NEURON FATE COMMITMENT |
6 |
67 |
0.000443 |
0.005872 |
351 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
6 |
67 |
0.000443 |
0.005872 |
352 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
23 |
724 |
0.0004463 |
0.005899 |
353 |
SINGLE ORGANISM CELL ADHESION |
17 |
459 |
0.0004657 |
0.006138 |
354 |
NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
3 |
11 |
0.0004707 |
0.006169 |
355 |
REGULATION OF CYTOKINE SECRETION INVOLVED IN IMMUNE RESPONSE |
3 |
11 |
0.0004707 |
0.006169 |
356 |
PATTERN SPECIFICATION PROCESS |
16 |
418 |
0.0004774 |
0.006239 |
357 |
ORGAN GROWTH |
6 |
68 |
0.00048 |
0.006256 |
358 |
NEGATIVE REGULATION OF RESPONSE TO WOUNDING |
9 |
156 |
0.0005014 |
0.006517 |
359 |
REGULATION OF NEUROTRANSMITTER LEVELS |
10 |
190 |
0.0005123 |
0.00664 |
360 |
NEGATIVE REGULATION OF OSSIFICATION |
6 |
69 |
0.0005193 |
0.006693 |
361 |
SYNAPSE ASSEMBLY |
6 |
69 |
0.0005193 |
0.006693 |
362 |
REGULATION OF MACROPHAGE ACTIVATION |
4 |
26 |
0.0005231 |
0.006724 |
363 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
10 |
191 |
0.0005337 |
0.006842 |
364 |
REGULATION OF CELLULAR LOCALIZATION |
34 |
1277 |
0.0005522 |
0.007059 |
365 |
GLAND MORPHOGENESIS |
7 |
97 |
0.0005626 |
0.007152 |
366 |
MUSCLE ORGAN MORPHOGENESIS |
6 |
70 |
0.0005611 |
0.007152 |
367 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
30 |
1079 |
0.0005924 |
0.007511 |
368 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
7 |
98 |
0.0005984 |
0.007546 |
369 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
7 |
98 |
0.0005984 |
0.007546 |
370 |
EXCITATORY POSTSYNAPTIC POTENTIAL |
4 |
27 |
0.0006071 |
0.007634 |
371 |
EMBRYONIC CAMERA TYPE EYE FORMATION |
3 |
12 |
0.0006207 |
0.007785 |
372 |
POSITIVE REGULATION OF TRANSPORT |
27 |
936 |
0.0006461 |
0.008082 |
373 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
9 |
162 |
0.0006586 |
0.008215 |
374 |
METENCEPHALON DEVELOPMENT |
7 |
100 |
0.0006755 |
0.008404 |
375 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
10 |
197 |
0.0006787 |
0.008421 |
376 |
POSITIVE REGULATION OF PROTEIN BINDING |
6 |
73 |
0.0007023 |
0.008578 |
377 |
PANCREAS DEVELOPMENT |
6 |
73 |
0.0007023 |
0.008578 |
378 |
REGULATION OF ORGAN GROWTH |
6 |
73 |
0.0007023 |
0.008578 |
379 |
REGULATION OF CELL GROWTH |
15 |
391 |
0.0006966 |
0.008578 |
380 |
LEARNING |
8 |
131 |
0.0007042 |
0.008578 |
381 |
REGULATION OF KERATINOCYTE PROLIFERATION |
4 |
28 |
0.0007002 |
0.008578 |
382 |
RETINA DEVELOPMENT IN CAMERA TYPE EYE |
8 |
131 |
0.0007042 |
0.008578 |
383 |
REGULATION OF EXTENT OF CELL GROWTH |
7 |
101 |
0.0007168 |
0.008668 |
384 |
CAMERA TYPE EYE MORPHOGENESIS |
7 |
101 |
0.0007168 |
0.008668 |
385 |
REGIONALIZATION |
13 |
311 |
0.0007172 |
0.008668 |
386 |
REGULATION OF HORMONE LEVELS |
17 |
478 |
0.0007328 |
0.008834 |
387 |
RESPONSE TO OXIDATIVE STRESS |
14 |
352 |
0.0007366 |
0.008856 |
388 |
REGULATION OF IMMUNE SYSTEM PROCESS |
36 |
1403 |
0.0007421 |
0.0089 |
389 |
RESPONSE TO INORGANIC SUBSTANCE |
17 |
479 |
0.00075 |
0.008971 |
390 |
CELLULAR RESPONSE TO PEPTIDE |
12 |
274 |
0.0007615 |
0.009085 |
391 |
GLAND DEVELOPMENT |
15 |
395 |
0.0007726 |
0.009194 |
392 |
MUSCLE TISSUE DEVELOPMENT |
12 |
275 |
0.0007861 |
0.00933 |
393 |
HEMATOPOIETIC STEM CELL PROLIFERATION |
3 |
13 |
0.0007983 |
0.009403 |
394 |
DIVALENT INORGANIC ANION HOMEOSTASIS |
3 |
13 |
0.0007983 |
0.009403 |
395 |
POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION |
3 |
13 |
0.0007983 |
0.009403 |
396 |
POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
4 |
29 |
0.0008029 |
0.009434 |
397 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
5 |
50 |
0.0008058 |
0.009445 |
398 |
ARTERY DEVELOPMENT |
6 |
75 |
0.0008108 |
0.009479 |